ArticleMedical science monitor : international medical journal of experimental and clinical research2012

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment.

Arzu Didem Yalcin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.